Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Ear Nose Throat J ; 100(1): NP7-NP15, 2021 Jan.
Article in English | MEDLINE | ID: mdl-31159573

ABSTRACT

The objective of this study was to evaluate the expression of survivin and p16 in laryngeal squamous cell carcinoma (LSCC) in order to analyze their pathogenesis and prognostic significance in Tunisian patients. A total of 70 patients with LSCC collected at the Salah Azaiez Cancer Institute of Tunis were retrospectively evaluated. Expression of survivin and p16 was examined using immunohistochemistry, and the correlations with clinicopathological parameters, overall survival (OS), and disease-free survival (DFS) were statistically evaluated. The positive expression of survivin and p16 were found in 58.6% and 51.43% of LSCC cases, respectively. The p16 expression was not associated with either clinical parameters or patient survival, whereas there was a strong correlation of survivin expression and lymph node metastases (P = .002), alcohol consumption (P = .024), and therapeutic protocol (with or without chemotherapy; P = .001). Kaplan-Meier survival curves showed that patients with LSCC having positive survivin expression have shorter OS (P = .026) and shorter DFS (P = .01) than those with negative expression. Positive survivin expression was also correlated with high recurrence rate (P = .014). Therefore, survivin is a poor prognostic marker for LSCC but the therapeutic protocol remains, in multivariate study, the most decisive for the OS and DFS of our patients with P < .01. Our data indicated that, in Tunisian laryngeal squamous cell carcinoma, survivin expression is associated with unfavorable outcomes and represents a predictor marker of recurrence and chemoresistance. However, p16 expression has no prognosis value.


Subject(s)
Carcinoma, Squamous Cell/genetics , Genes, p16 , Laryngeal Neoplasms/genetics , Survivin/metabolism , Aged , Aged, 80 and over , Carcinoma, Squamous Cell/mortality , Disease-Free Survival , Drug Resistance, Neoplasm/genetics , Female , Gene Expression/genetics , Humans , Immunohistochemistry , Kaplan-Meier Estimate , Laryngeal Neoplasms/mortality , Lymphatic Metastasis/genetics , Male , Middle Aged , Multivariate Analysis , Prognosis , Retrospective Studies , Survival Rate , Tunisia/epidemiology
2.
Mol Genet Genomic Med ; 6(6): 933-940, 2018 11.
Article in English | MEDLINE | ID: mdl-30160047

ABSTRACT

BACKGROUND: Nasopharyngeal carcinoma (NPC) has a higher incidence in North Africa than in most parts of the world. In addition to environmental factors such as Epstein-Barr virus infection and chemical carcinogen exposure, genetic susceptibility has been reported to play a key role in the development of NPC. NAD(P)H: quinone oxidoreductase 1 is a cytosolic enzyme that protects cells from oxidative damage. A C to T transition at position 609 in the NQO1 gene (OMIM: 125860) has been shown to alter the enzymatic activity of the enzyme and has been associated with increased risk to several cancers. This study investigates for the first time the effect of this polymorphism on NPC susceptibility in a North African population. METHODS: The NQO1 C609T polymorphism was genotyped using PCR-RFLP in 392 NPC cases and 365 controls from Morocco, Algeria, and Tunisia. RESULTS: The allele frequencies and distributions of genotypes did not differ between cases and controls (p > 0.05). When stratifying according to smoking status, we observed two-fold higher NPC risk in ever-smokers carrying the CT or TT genotype. Multiple logistic regression analysis revealed that there was a significant interaction between T allele and smoking status (OR = 1.95, 95% CI = 1.20-3.19; interaction p = 0.007). CONCLUSION: In this North African population, the functional NQO1 polymorphism was associated with a significantly higher risk of NPC among smokers and did not affect the risk among nonsmokers.


Subject(s)
NAD(P)H Dehydrogenase (Quinone)/genetics , Nasopharyngeal Carcinoma/genetics , Nasopharyngeal Neoplasms/genetics , Polymorphism, Single Nucleotide , Smoking/epidemiology , Adult , Africa, Northern , Female , Humans , Male , Middle Aged , Nasopharyngeal Carcinoma/epidemiology , Nasopharyngeal Neoplasms/epidemiology
3.
Bull Cancer ; 104(5): 433-441, 2017 May.
Article in English | MEDLINE | ID: mdl-28185633

ABSTRACT

AIMS: The objective of this study was to compare the protein expression profile between well-differentiated (papillary) and undifferentiated (anaplastic) thyroid carcinoma in Tunisian patients. METHODS: This first Tunisian retrospective study concerned data of 38 thyroid cancer cases (19 papillary carcinoma PTC and 19 anaplastic carcinoma ATC) collected at Salah Azaiez Institute of Tunisia. Immunohistochemistry was used to evaluate tumor expression of different molecular markers (p53, Ki67, E-cadherin, cyclin D1, bcl2, S100 and Her-2). The molecular expression was correlated with the clinicopathological characteristics of the tumors. RESULTS: There were 6 differentially expressed markers when comparing anaplastic thyroid carcinoma ATC with papillary thyroid carcinoma PTC. Expression of p53 and Ki67 were significantly increased in 16 and 18 ATC cases respectively, the Ki67 expression was lost in PTC. Cyclin D1, E-cadherin, bcl2 and S100 were overexpressed in PTC tumors; however, they were significantly decreased in ATC. The last marker, Her-2 was expressed in one case of PTC only. CONCLUSION: Our results, similar with findings of other ethnic groups, showed alteration in expression of molecular markers associated with tumor dedifferentiation, indicating loss of cell cycle control with increased proliferative activity in ATC carcinoma. These data support the hypothesis that ATC may derive from dedifferentiation of preexisting PTC tumor.


Subject(s)
Biomarkers, Tumor/metabolism , Carcinoma, Papillary/metabolism , Thyroid Carcinoma, Anaplastic/metabolism , Thyroid Neoplasms/metabolism , Adult , Aged , Cadherins/metabolism , Carcinoma, Papillary/pathology , Cyclin D1/metabolism , Female , Humans , Ki-67 Antigen/metabolism , Male , Middle Aged , Proto-Oncogene Proteins c-bcl-2/metabolism , Receptor, ErbB-2/metabolism , Retrospective Studies , S100 Proteins/metabolism , Thyroid Carcinoma, Anaplastic/pathology , Thyroid Neoplasms/pathology , Tumor Suppressor Protein p53/metabolism , Tunisia
4.
BMC Med Genet ; 17(1): 72, 2016 Oct 12.
Article in English | MEDLINE | ID: mdl-27733130

ABSTRACT

BACKGROUND: Genetic susceptibility plays a key role in the development of nasopharyngeal carcinoma (NPC) and in fact the disease presents with an unusually high incidence in certain regions of the world like North Africa. We investigated the association between polymorphism of the Transforming growth factor-ß1 (TGF-ß1) and risk of NPC in North Africa. TGF-ß1 is a multifunctional cytokine that acts as both a tumor suppressor and a stimulator of cancer development; it has been shown to influence risk of numerous other carcinomas including lung, breast and prostate cancer. METHODS: TGF-ß1 polymorphisms C-509T and T869C were studied in a large North African sample of 384 NPC cases and 361 controls, matched for age, sex and urban or rural residence in childhood. Genotypes were determined using polymerase chain reaction-restriction fragment length polymorphism. RESULTS: No association was observed between individual single nucleotide polymorphisms or their haplotypes and NPC susceptibility (for TGF-ß1 C-509T: OR = 0.74; 95 % CI 0.46 - 1.18; for TGF-ß1 T869C: OR = 0.86; 95 % CI 0.56 - 1.31), even when the samples were stratified by age, gender and TNM stage. CONCLUSION: Contrary to what has been observed in Asian samples, in our North African sample, the TGF-ß1 C-509T and T869C polymorphisms did not substantially influence NPC susceptibility.


Subject(s)
Nasopharyngeal Neoplasms/genetics , Polymorphism, Single Nucleotide/genetics , Transforming Growth Factor beta1/genetics , Adult , Africa, Northern , Alleles , Carcinoma , Case-Control Studies , DNA/chemistry , DNA/isolation & purification , DNA/metabolism , Female , Gene Frequency , Genetic Predisposition to Disease , Genotype , Haplotypes , Humans , Male , Middle Aged , Nasopharyngeal Carcinoma , Nasopharyngeal Neoplasms/pathology , Odds Ratio
5.
Tunis Med ; 93(6): 361-4, 2015 Jun.
Article in French | MEDLINE | ID: mdl-26644098

ABSTRACT

BACKGROUND: Despite legislative acts develloped, many deficiencies were identified in blood requests at the National Blood TransfusionCenter impedding board and blood safety. AIM: to evaluate the conformity of the different topics of packed red blood cells requests to the legislation. METHODS: Our study was prospective descriptive lasting six months (March-August 2011). It assessed all packed red blood cells requests which reached the national blood transfusion center. RESULTS: 16064 packed red blood cells requests from 21 public institutions and 28 private institutions were studied. There was different deficiencies in each item.The absence of birth date in 67.18% of request represented the largest non-compliance within administrative information. A predominance of shortcomings related to transfusion and obstetric history was recorded for clinical information with absence of date of the last transfusion in 91.72% cases, lack of accuracy of any previous transfusion reactions in 88.63% cases and absence of the number of previous pregnancies in 93.15% of transfusion requests prescribed to women. Non-conformities related to the prescribing physician concerned mainly the phone number which was absent in 55.82% of cases. CONCLUSIONS: This study revealed a significant lack of awareness of physicians in relation to the law governing transfusion. It is therefore essential to develop training for prescribers to improve transfusion safety.


Subject(s)
Blood Banks/standards , Blood Preservation/standards , Erythrocyte Transfusion/standards , Guideline Adherence , Practice Patterns, Physicians'/standards , Prescriptions/standards , Quality Assurance, Health Care , Adult , Blood Preservation/statistics & numerical data , Blood Safety , Clinical Competence/standards , Erythrocyte Transfusion/statistics & numerical data , Female , Humans , Postpartum Hemorrhage/therapy , Practice Guidelines as Topic , Practice Patterns, Physicians'/statistics & numerical data , Pregnancy , Prescriptions/statistics & numerical data , Prospective Studies , Tunisia
SELECTION OF CITATIONS
SEARCH DETAIL
...